Top Investor Moves, $BDX Investment Case, $BHVN Insider Moves, $CEG Government Loan and More
Welcome back to the BBAE Blog, your trusted source for the latest investment insights and analyses from the BBAE team. This week, we’re excited to share some highlights that will keep you informed and ahead of the market. Don’t forget, some of our most valuable insights are available exclusively in the BBAE Pro app—download it now to unlock full access!
- 13F Highlights: Where Top Investors Moved in Q3 2025
- Hinde Group: Becton, Dickinson and Company ($BDX) Investment Case
- Biohaven ($BHVN) Insiders Step In After FDA Setback
- Trending Tickers: $CEG Government Loan, $MP Saudi JV, $ADBE Semrush Acquisition
Need a reminder of why BBAE? We have one goal: to provide you with exclusive content and data to help you make informed investing decisions. Explore a wealth of market insights and potential investing opportunities that you can’t find anywhere else.
13F Highlights: Where Top Investors Moved in Q3 2025
The Q3 2025 13F filings reveal a wave of decisive shifts among top investors, with each taking a very different stance on the AI rally and broader market. Michael Burry flipped from his Q2 bullish positioning to a defensive, bearish setup, unloading prior call options, doubling his Lululemon stake, and opening fresh put positions against Nvidia and Palantir. Warren Buffett made one of his rare big tech pivots by initiating a multibillion-dollar stake in Alphabet while trimming Apple again ahead of Berkshire’s leadership transition. Bill Ackman stayed largely on the sidelines with only minor trims, while Ray Dalio’s Bridgewater scaled back mega cap AI winners and rotated heavily into semiconductors and Netflix. Read the full breakdown here.
Hinde Group: Becton, Dickinson and Company ($BDX) Investment Case
Hinde Group’s Q3 2025 letter introduces Becton, Dickinson as their first new position since 2022, highlighting an “almost-great business” with leading market shares, 54.7% gross margins, 40%+ ROIC, and exceptional recession-resilience, trading at less than 10x pro forma fiscal 2026 earnings—deeply undervalued in absolute terms. The investment thesis centers on the Q1 2026 Reverse Morris Trust transaction with Waters Corporation monetizing Biosciences & Diagnostics Solutions businesses for $18.8 billion (~$65 per BDX share) at 5.7x revenue and 25x+ profit, removing growth overhangs while “New BD” retains mid-single digit organic growth with margin expansion driving high-single digit EPS growth. With management committed to aggressive share repurchases ($2+ billion from transaction proceeds plus $1-2 billion from free cash flow), a 2026 analyst day, and dissipating headwinds, Hinde sees fair value of ~$300 per share by end of 2027. Read the full article here.
Biohaven ($BHVN) Insiders Step In After FDA Setback
Two Biohaven Ltd. ($BHVN) insiders made substantial purchases after the company’s stock plunged more than 50 percent following the FDA’s rejection of its experimental treatment for spinocerebellar ataxia. Director John W. Childs bought 3,333,333 shares at $7.50 each, investing $25 million and boosting his holdings by 50.94 percent. The CEO purchased 666,666 shares for $5 million at the same price, increasing their position by 20.99 percent. The purchases were part of a public offering and took place as the company began restructuring its business priorities, including a plan to cut direct R&D spending by about 60 percent. Could these insider moves signal confidence in a turnaround or simply an attempt to restore investor sentiment after a major setback? You can track insider activity like this daily with InsiderEdge, available in the BBAE app.
Trending Tickers: $CEG Government Loan, $MP Saudi JV, $ADBE Semrush Acquisition
This week, several stocks attracted attention due to major developments. Here’s a breakdown:
- Constellation ($CEG): Constellation secured a $1 billion U.S. Department of Energy loan to restart its Crane nuclear plant, adding 835 MW of new carbon-free baseload power to the grid. The project supports surging AI and electrification demand while creating thousands of jobs and strengthening U.S. energy security.
- MP Materials ($MP): MP announced a rare earth refining joint venture with Saudi Arabia’s Maaden as part of a U.S.–Saudi critical minerals framework. The venture diversifies supply chains away from China and expands MP’s global refining footprint with a capital-light structure supported by U.S. government funding.
- Adobe ($ADBE): Adobe agreed to acquire Semrush ($SEMR) for $1.9 billion in cash, integrating its SEO and generative engine optimization tools into Adobe Experience Cloud. The deal enhances Adobe’s marketing and brand-visibility capabilities as AI assistants reshape digital discovery.
Read the full Weekly Highlights article here.
This article is for informational purposes only and is neither investment advice nor a solicitation to buy or sell securities. All investment involves inherent risks, including the total loss of principal, and past performance is not a guarantee of future results. Always conduct thorough research or consult with a financial expert before making any investment decisions. BBAE has no position in any investment mentioned.
